G. Depowska

Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy

W. Majewski, G. Goldner, R. Suwiński, 2022, Biomedicines.

Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer

W. Majewski, P. Wojcieszek, M. Miszczyk, 2022, Journal of contemporary brachytherapy.

Brachytherapy boost improves survival and decreases risk of developing distant metastases compared to external beam radiotherapy alone in intermediate and high risk group prostate cancer patients.

W. Majewski, G. Goldner, R. Suwiński, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost.

G. Heilemann, R. Suwiński, P. Wojcieszek, 2024, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Does Brachytherapy Boost Improve Biochemical Control in Intermediate and High-Risk Prostate Cancer Patients Compared to External Beam Radiotherapy Alone?

W. Majewski, E. Nowicka, R. Suwiński, 2021, International journal of radiation oncology, biology, physics.